ALLISON DAUBERGER: Open Payments
NPI 1477151462 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$369 in 15 payments from 8 companies in 2025. Trend: 2023 $79 · 2024 $537 · 2025 $369
Food & beverage: $369
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $106 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Actelion Pharmaceuticals US, Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| CVRx, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Novo Nordisk Inc | 1 | $17 |
Products named: Kerendia, AMVUTTRA, OPSUMIT, VERQUVO, FARXIGA, Barostim Neo System, CAMZYOS, WAINUA.
Industry payments across GA — which companies pay providers there.
